James R. Engle
Chief Tech/Sci/R&D Officer chez Talecris Biotherapeutics Holdings Corp.
Profil
James R.
Engle is a professional who has worked in various senior vice president-information technology roles.
He is currently employed at Talecris Biotherapeutics Holdings Corp.
as a Senior Vice President-Information Technology since 2005.
Prior to this, he worked at Aventis, Inc. as a Senior Vice President-Information Technology from 1988 to 2004.
He also worked at CSL Behring LLC as a Chief Information Officer.
Mr. Engle completed his undergraduate degree from Delaware Valley University.
Postes actifs de James R. Engle
| Sociétés | Poste | Début |
|---|---|---|
Talecris Biotherapeutics Holdings Corp.
 Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Chief Tech/Sci/R&D Officer | 24/03/2010 |
Anciens postes connus de James R. Engle
| Sociétés | Poste | Fin |
|---|---|---|
| Aventis, Inc. | Chief Tech/Sci/R&D Officer | 01/01/2004 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Chief Tech/Sci/R&D Officer | - |
Formation de James R. Engle
| Delaware Valley University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| Aventis, Inc. | |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Health Technology |
